# Novalis LifeSciences

Novalis LifeSciences is a Private Equity based in Hampton, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Hampton, United States
- **Region:** North America
- **Address:** 170 Commerce Way, Suite 200, Portsmouth, NH 03801, USA
- **Founded:** 2017
- **Assets under management:** $500M (per the firm)
- **Website:** www.novalislifesciences.com
- **LinkedIn:** https://www.linkedin.com/company/novalis-lifesciences-llc

## Regulatory record

- **CRD number:** 304156
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/304156

## About

Novalis LifeSciences is a state-registered investment adviser with its headquarters in Hampton, NH. It provides investment advice to clients. The firm focuses on healthcare and life sciences investments.

## Sectors

- Healthcare Services
- Enterprise Software
- AI/ML

## Offices

- Boston, MA, USA

## People

- Marijn Dekkers — Chairman
- Paul Meister — Partner
- Dino Pantelis — COO
- Devin Leake — Managing Director
- Michael Alter — Managing Director
- Greg Herrema — Senior Advisor

## Questions

### Who runs investment decisions at Novalis LifeSciences?

Marijn Dekkers, the firm's Chairman and founder, leads investment decisions with Partner Paul Meister. Dekkers was previously CEO of Bayer and Thermo Fisher Scientific; Meister was Chairman of Thermo Fisher and co-founder of Liberty Lane Partners. The two draw on decades of operating experience running global life science companies.

### How does Novalis LifeSciences source its deals?

Novalis sources deals partly through its dual structure: the Novalis Advisory unit provides strategic and investment banking services to life science companies, creating a pipeline of firms the partners already know operationally. The firm's senior team, including former Thermo Fisher executives, also leverages a deep network across the diagnostics, tools, and biopharma sectors.

### What is the relationship between Novalis LifeSciences and Novalis Advisory?

Novalis LifeSciences is the direct investment vehicle that manages venture capital and private equity funds. Novalis Advisory is a separate unit under the same parent, Novalis Capital Partners, offering strategic advisory, investment banking, and leadership coaching to life science companies. The two entities share leadership and often interact with the same companies in different capacities.

### Does Novalis LifeSciences invest at a specific stage?

The firm invests from early-stage venture rounds through growth and late-stage expansion, across life science tools, diagnostics, and biopharma. Portfolio companies span pre-revenue platform developers like Helaxy and commercial-stage public companies such as Cerevel Therapeutics before its acquisition.

### Where does Novalis LifeSciences typically invest geographically?

Novalis invests globally, with current and exited portfolio companies headquartered in the United States, Germany, the United Kingdom, Belgium, the Netherlands, and Singapore. Its own offices are in Portsmouth, New Hampshire, and Boston, Massachusetts.

### Has Novalis LifeSciences had notable exits?

Yes. Confirmed exits include Cerevel Therapeutics (acquired by AbbVie in August 2024), Decipher Biosciences (acquired by Veracyte in March 2021), Celsee (acquired by Bio-Rad in April 2020), and the public listings of Quanterix and Ginkgo Bioworks.

## Related profiles

- [Novalis Biotech](https://altss.com/profile/novalis-biotech)
- [Novamind Ventures](https://altss.com/profile/novamind-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/novalis-lifesciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology